Causes, diagnosis, and treatment of central precocious puberty

Lancet Diabetes and Endocrinology,The - Tập 4 - Trang 265-274 - 2016
Ana Claudia Latronico1, Vinicius Nahime Brito1, Jean-Claude Carel2,3,4
1Disciplina de Endocrinologia e Metabologia, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
2Univ Paris Diderot, Sorbonne Paris Cité, Paris, France
3Department of Pediatric Endocrinology and Diabetology, Hôpital Robert Debré, and Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Paris, France
4Institut National de la Santé et de la Recherche Médicale U1141, Paris, France

Tài liệu tham khảo

Parent, 2003, The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration, Endocr Rev, 24, 668, 10.1210/er.2002-0019 Marshall, 1970, Variations in the pattern of pubertal changes in boys, Arch Dis Child, 45, 13, 10.1136/adc.45.239.13 Marshall, 1969, Variations in pattern of pubertal changes in girls, Arch Dis Child, 44, 291, 10.1136/adc.44.235.291 Herman-Giddens, 1997, Secondary sexual characteristics and menses in young girls seen in office practice: a study from the Pediatric Research in Office Settings network, Pediatrics, 99, 505, 10.1542/peds.99.4.505 Aksglaede, 2009, Recent decline in age at breast development: the Copenhagen Puberty Study, Pediatrics, 123, e932, 10.1542/peds.2008-2491 Roelants, 2009, References for growth and pubertal development from birth to 21 years in Flanders, Belgium, Ann Hum Biol, 36, 680, 10.3109/03014460903049074 Biro, 2013, Onset of breast development in a longitudinal cohort, Pediatrics, 132, 1019, 10.1542/peds.2012-3773 Willemsen, 2014, Pros and cons of GnRHa treatment for early puberty in girls, Nat Rev Endocrinol, 10, 352, 10.1038/nrendo.2014.40 Kaplowitz, 2011, Update on precocious puberty: girls are showing signs of puberty earlier, but most do not require treatment, Adv Pediatr, 58, 243, 10.1016/j.yapd.2011.03.004 Partsch, 2001, Pathogenesis and epidemiology of precocious puberty. Effects of exogenous oestrogens, Hum Reprod Update, 7, 292, 10.1093/humupd/7.3.292 Teilmann, 2005, Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries, Pediatrics, 116, 1323, 10.1542/peds.2005-0012 Lakshman, 2009, Early age at menarche associated with cardiovascular disease and mortality, J Clin Endocrinol Metab, 94, 4953, 10.1210/jc.2009-1789 Prentice, 2013, Pubertal timing and adult obesity and cardiometabolic risk in women and men: a systematic review and meta-analysis, Int J Obes (Lond), 37, 1036, 10.1038/ijo.2012.177 Ritte, 2013, Height, age at menarche and risk of hormone receptor-positive and -negative breast cancer: a cohort study, Int J Cancer, 132, 2619, 10.1002/ijc.27913 2012, Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies, Lancet Oncol, 13, 1141, 10.1016/S1470-2045(12)70425-4 Carel, 2009, Consensus statement on the use of gonadotropin-releasing hormone analogs in children, Pediatrics, 123, e752, 10.1542/peds.2008-1783 Xhrouet-Heinrichs, 1997, Longitudinal study of behavioral and affective patterns in girls with central precocious puberty during long-acting triptorelin therapy, Acta Paediatr, 86, 808, 10.1111/j.1651-2227.1997.tb08602.x Carel, 2008, Precocious puberty, N Engl J Med, 358, 2366, 10.1056/NEJMcp0800459 Partsch, 2002, Management and outcome of central precocious puberty, Clin Endocrinol (Oxf), 56, 129, 10.1046/j.0300-0664.2001.01490.x Stephen, 2011, Gonadotropin-dependent precocious puberty: neoplastic causes and endocrine considerations, Int J Pediatr Endocrinol, 2011, 184502, 10.1155/2011/184502 de Brito, 1999, Treatment of gonadotropin dependent precocious puberty due to hypothalamic hamartoma with gonadotropin releasing hormone agonist depot, Arch Dis Child, 80, 231, 10.1136/adc.80.3.231 Jung, 2002, Pathogenesis of precocious puberty in hypothalamic hamartoma, Horm Res, 57, 31 Cukier, 2013, The benign spectrum of hypothalamic hamartomas: infrequent epilepsy and normal cognition in patients presenting with central precocious puberty, Seizure, 22, 28, 10.1016/j.seizure.2012.09.013 Teilmann, 2006, Increased risk of precocious puberty in internationally adopted children in Denmark, Pediatrics, 118, e391, 10.1542/peds.2005-2939 Mouritsen, 2010, Hypothesis: exposure to endocrine-disrupting chemicals may interfere with timing of puberty, Int J Androl, 33, 346, 10.1111/j.1365-2605.2010.01051.x Parent, 2015, Developmental variations in environmental influences including endocrine disruptors on pubertal timing and neuroendocrine control: revision of human observations and mechanistic insight from rodents, Front Neuroendocrinol, 38, 12, 10.1016/j.yfrne.2014.12.004 Rasier, 2008, Mechanisms of interaction of endocrine-disrupting chemicals with glutamate-evoked secretion of gonadotropin-releasing hormone, Toxicol Sci, 102, 33, 10.1093/toxsci/kfm285 Deng, 2012, Effects of growth environments and two environmental endocrine disruptors on children with idiopathic precocious puberty, Eur J Endocrinol, 166, 803, 10.1530/EJE-11-0876 Denham, 2005, Relationship of lead, mercury, mirex, dichlorodiphenyldichloroethylene, hexachlorobenzene, and polychlorinated biphenyls to timing of menarche among Akwesasne Mohawk girls, Pediatrics, 115, e127, 10.1542/peds.2004-1161 Ozen, 2012, Effects of pesticides used in agriculture on the development of precocious puberty, Environ Monit Assess, 184, 4223, 10.1007/s10661-011-2257-6 Brito, 2008, Update on the etiology, diagnosis and therapeutic management of sexual precocity, Arq Bras Endocrinol Metabol, 52, 18, 10.1590/S0004-27302008000100005 Kumar, 2015, Challenges and controversies in diagnosis and management of gonadotropin dependent precocious puberty: an Indian perspective, Indian J Endocrinol Metab, 19, 228, 10.4103/2230-8210.149316 Teles, 2008, A GPR54-activating mutation in a patient with central precocious puberty, N Engl J Med, 358, 709, 10.1056/NEJMoa073443 Silveira, 2010, Mutations of the KISS1 gene in disorders of puberty, J Clin Endocrinol Metab, 95, 2276, 10.1210/jc.2009-2421 Abreu, 2013, Central precocious puberty caused by mutations in the imprinted gene MKRN3, N Engl J Med, 368, 2467, 10.1056/NEJMoa1302160 Macedo, 2014, Central precocious puberty that appears to be sporadic caused by paternally inherited mutations in the imprinted gene makorin ring finger 3, J Clin Endocrinol Metab, 99, E1097, 10.1210/jc.2013-3126 Settas, 2014, Central precocious puberty in a girl and early puberty in her brother caused by a novel mutation in the MKRN3 gene, J Clin Endocrinol Metab, 99, E647, 10.1210/jc.2013-4084 Schreiner, 2014, MKRN3 mutations in familial central precocious puberty, Horm Res Paediatr, 82, 122, 10.1159/000362815 de Vries, 2014, A novel MKRN3 missense mutation causing familial precocious puberty, Hum Reprod, 29, 2838, 10.1093/humrep/deu256 Bulcao Macedo, 2014, New causes of central precocious puberty: the role of genetic factors, Neuroendocrinology, 100, 1, 10.1159/000366282 Neocleous, 2015, In silico analysis of a novel MKRN3 missense mutation in familial central precocious puberty, Clin Endocrinol (Oxf) Lee, 2015, Low frequency of MKRN3 mutations in central precocious puberty among Korean girls, Horm Metab Res Partsch, 2002, Central precocious puberty in girls with Williams syndrome, J Pediatr, 141, 441, 10.1067/mpd.2002.127280 Cisternino, 2013, Idiopathic central precocious puberty associated with 11 mb de novo distal deletion of the chromosome 9 short arm, Case Rep Genet, 2013, 978087 Hoffmann, 2011, Uniparental disomies 7 and 14, Best Pract Res Clin Endocrinol Metab, 25, 77, 10.1016/j.beem.2010.09.004 Grosso, 2001, Pubertal disorders in inv dup(15) syndrome, Gynecol Endocrinol, 15, 165, 10.1080/gye.15.3.165.169 Cassidy, 2012, Prader–Willi syndrome, Genet Med, 14, 10, 10.1038/gim.0b013e31822bead0 Saletti, 2009, A CDKL5 mutated child with precocious puberty, Am J Med Genet A, 149A, 1046, 10.1002/ajmg.a.32806 Brito, 1999, Diagnostic value of fluorometric assays in the evaluation of precocious puberty, J Clin Endocrinol Metab, 84, 3539 Neely, 1995, Normal ranges for immunochemiluminometric gonadotropin assays, J Pediatr, 127, 40, 10.1016/S0022-3476(95)70254-7 Houk, 2009, Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls, Pediatrics, 123, e1059, 10.1542/peds.2008-1180 Lee, 2013, Basal luteinizing hormone and follicular stimulating hormone: is it sufficient for the diagnosis of precocious puberty in girls?, Ann Pediatr Endocrinol Metab, 18, 196, 10.6065/apem.2013.18.4.196 Pasternak, 2012, The utility of basal serum LH in prediction of central precocious puberty in girls, Eur J Endocrinol, 166, 295, 10.1530/EJE-11-0720 Freire, 2013, High diagnostic accuracy of subcutaneous triptorelin test compared with GnRH test for diagnosing central precocious puberty in girls, Clin Endocrinol (Oxf), 78, 398, 10.1111/j.1365-2265.2012.04517.x Cavallo, 1995, A simplified gonadotrophin-releasing hormone test for precocious puberty, Clin Endocrinol (Oxf), 42, 641, 10.1111/j.1365-2265.1995.tb02692.x Lawson, 1999, A single sample subcutaneous luteinizing hormone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists, J Clin Endocrinol Metab, 84, 4536 Carretto, 2014, The usefulness of the leuprolide stimulation test as a diagnostic method of idiopathic central precocious puberty in girls, Horm Metab Res, 46, 959, 10.1055/s-0034-1387790 Ketha, 2014, Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century, Curr Opin Endocrinol Diabetes Obes, 21, 217, 10.1097/MED.0000000000000068 Hagen, 2015, Circulating MKRN3 levels decline prior to pubertal onset and through puberty: a longitudinal study of healthy girls, J Clin Endocrinol Metab, 100, 1920, 10.1210/jc.2014-4462 Brito, 2008, Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs, J Clin Endocrinol Metab, 93, 2662, 10.1210/jc.2007-2183 Carel, 2004, Precocious puberty and statural growth, Hum Reprod Update, 10, 135, 10.1093/humupd/dmh012 de Vries, 2011, Pelvic ultrasound examination in girls with precocious puberty is a useful adjunct in gonadotrophin-releasing hormone analogue therapy monitoring, Clin Endocrinol (Oxf), 75, 372, 10.1111/j.1365-2265.2011.04086.x Sathasivam, 2011, Pelvic ultrasonography in the evaluation of central precocious puberty: comparison with leuprolide stimulation test, J Pediatr, 159, 490, 10.1016/j.jpeds.2011.02.032 Mogensen, 2012, Pathological and incidental findings on brain MRI in a single-center study of 229 consecutive girls with early or precocious puberty, PLoS One, 7, e29829, 10.1371/journal.pone.0029829 Pedicelli, 2014, Routine screening by brain magnetic resonance imaging is not indicated in every girl with onset of puberty between the ages of 6 and 8 years, J Clin Endocrinol Metab, 99, 4455, 10.1210/jc.2014-2702 de Vries, 2010, Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty, J Pediatr, 156, 466, 10.1016/j.jpeds.2009.09.071 Williams, 2012, Premature adrenarche, Arch Dis Child, 97, 250, 10.1136/archdischild-2011-300011 Léger, 2000, Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?, J Pediatr, 137, 819, 10.1067/mpd.2000.109201 Lazar, 2007, Growth pattern and final height after cessation of gonadotropin-suppressive therapy in girls with central sexual precocity, J Clin Endocrinol Metab, 92, 3483, 10.1210/jc.2007-0321 Lahlou, 2000, Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics, J Pediatr Endocrinol Metab, 13, 723 Lewis, 2013, Random luteinizing hormone often remains pubertal in children treated with the histrelin implant for central precocious puberty, J Pediatr, 162, 562, 10.1016/j.jpeds.2012.08.038 Brito, 2004, A single luteinizing hormone determination 2 hours after depot leuprolide is useful for therapy monitoring of gonadotropin-dependent precocious puberty in girls, J Clin Endocrinol Metab, 89, 4338, 10.1210/jc.2003-031537 Bhatia, 2002, Serum luteinizing hormone rises within minutes after depot leuprolide injection: implications for monitoring therapy, Pediatrics, 109, E30, 10.1542/peds.109.2.e30 Badaru, 2006, Sequential comparisons of one-month and three-month depot leuprolide regimens in central precocious puberty, J Clin Endocrinol Metab, 91, 1862, 10.1210/jc.2005-1500 Carel, 1999, Final height after long-term treatment with triptorelin slow release for central precocious puberty: importance of statural growth after interruption of treatment, J Clin Endocrinol Metab, 84, 1973, 10.1210/jcem.84.6.5647 Heger, 2006, Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function, Mol Cell Endocrinol, 254–255, 217, 10.1016/j.mce.2006.04.012 Gillis, 2013, Time to menarche and final height after histrelin implant treatment for central precocious puberty, J Pediatr, 163, 532, 10.1016/j.jpeds.2013.01.021 Pasquino, 1999, Adult height in girls with central precocious puberty treated with gonadotropin-releasing hormone analogues and growth hormone, J Clin Endocrinol Metab, 84, 449, 10.1210/jcem.84.2.5431 Vottero, 2006, Final height in girls with central idiopathic precocious puberty treated with gonadotropin-releasing hormone analog and oxandrolone, J Clin Endocrinol Metab, 91, 1284, 10.1210/jc.2005-1693 Silverman, 2015, Long-term continuous suppression with once-yearly histrelin subcutaneous implants for the treatment of central precocious puberty: a final report of a phase 3 multicenter trial, J Clin Endocrinol Metab, 100, 2354, 10.1210/jc.2014-3031 Lewis, 2013, A single histrelin implant is effective for 2 years for treatment of central precocious puberty, J Pediatr, 163, 1214, 10.1016/j.jpeds.2013.05.033 Carel, 2002, Treatment of central precocious puberty by subcutaneous injections of leuprorelin 3-month depot (11·25 mg), J Clin Endocrinol Metab, 87, 4111, 10.1210/jc.2001-020243 Johnson, 2012, Sterile abscess formation associated with depot leuprorelin acetate therapy for central precocious puberty, J Paediatr Child Health, 48, E136, 10.1111/j.1440-1754.2011.02083.x Lazar, 2014, Treated and untreated women with idiopathic precocious puberty: long-term follow-up and reproductive outcome between the third and fifth decades, Clin Endocrinol (Oxf), 80, 570, 10.1111/cen.12319 Castaño De La Mota, 2012, Hypothalamic hamartoma in paediatric patients: clinical characteristics, outcomes and review of the literature, Neurologia, 27, 268, 10.1016/j.nrl.2011.12.008